Kent E. Kester

A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine against<i>Plasmodium falciparum</i><i>Malaria</i>

José A. Stoute, M. Slaoui, D. Gray Heppner et al. · New England Journal of Medicine · 1997 · 874 citations · Full text

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

Samuel McConkey, William H. H. Reece, Vasee Moorthy et al. · Nature Medicine · 2003 · 557 citations · Full text

Vaccination, Vaccine Development, Immunology +8

Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

Kent E. Kester, James F. Cummings, Opokua Ofori‐Anyinam et al. · The Journal of Infectious Diseases · 2009 · 533 citations · Full text

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

Kalifa Bojang, Paul Milligan, Margaret Pinder et al. · The Lancet · 2001 · 526 citations

Vaccination, Plasmodium Falciparum Infection, Randomised Trial +7

Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against Experimental<i>Plasmodium falciparum</i>Malaria

Kent E. Kester, Denise McKinney, Nadia Tornieporth et al. · The Journal of Infectious Diseases · 2001 · 270 citations · Full text